Back
Longeveron 10K Form
Sell
29
LGVN
Longeveron
Last Price:
1.27
Seasonality Move:
-17.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-03-30 | 10K | LGVN/Longeveron Annual |
Receive LGVN News And Ratings
See the #1 stock for the next 7 days that we like better than LGVN
LGVN Financial Statistics
Sales & Book Value
| Annual Sales: | $709K |
|---|---|
| Cash Flow: | $-4.26M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.68 |
| Price / Book: | 0.48 |
Profitability
| EPS (TTM): | -10.20000 |
|---|---|
| Net Income (TTM): | $-21.41M |
| Gross Margin: | $221K |
| Return on Equity: | -174.21% |
| Return on Assets: | -118.94% |
Longeveron Earnings Forecast
Key Longeveron Financial Ratios
- The Gross Profit Margin over the past 6 years for LGVN is 31.17%.
- The Selling, General & Administrative Expenses for LGVN have been equal to 1,718.48% of Gross Profit Margin.
- The Research & Development expenses have been 1,278.70% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of LGVN is -3,020.17% of Total Revenues.
- Per Share Earnings over the last 6 years have been positive in 2 years.
Longeveron Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | LGVN |
| Website: | longeveron.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.5 |
| Quick Ratio: | 1.41 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
LGVN Technical Analysis vs Fundamental Analysis
Sell
29
Longeveron (LGVN)
is a Sell
Is Longeveron a Buy or a Sell?
-
Longeveron stock is rated a Sell
The current Longeveron [LGVN] share price is $1.28. The Score for LGVN is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.